Correction to "Preoperative Gemcitabine/Nab-Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer: A Comparative Analysis With Preoperative Chemoradiation Therapy Using Gemcitabine Alone".

Author unknown

Open source

DOI
10.1002/ags3.70277
Published
2026 Sep 3
Container
Annals of gastroenterological surgery
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ags3.70277,
  title = {Correction to "Preoperative Gemcitabine/Nab-Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer: A Comparative Analysis With Preoperative Chemoradiation Therapy Using Gemcitabine Alone".},
  year = {2026},
  journal = {Annals of gastroenterological surgery},
  doi = {10.1002/ags3.70277},
  url = {https://doi.org/10.1002/ags3.70277}
}

RIS

TY  - JOUR
TI  - Correction to "Preoperative Gemcitabine/Nab-Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer: A Comparative Analysis With Preoperative Chemoradiation Therapy Using Gemcitabine Alone".
PY  - 2026
JO  - Annals of gastroenterological surgery
DO  - 10.1002/ags3.70277
UR  - https://doi.org/10.1002/ags3.70277
ER  - 

APA

Correction to "Preoperative Gemcitabine/Nab-Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer: A Comparative Analysis With Preoperative Chemoradiation Therapy Using Gemcitabine Alone".. (2026). Annals of gastroenterological surgery. https://doi.org/10.1002/ags3.70277

Source records